( The study protocol was approved by the Institutional Ethical Committee, KEM Hospital and Research Centre, Pune
Conclusion Health insurers are likely to be or have already been exposed to the rise of GLP-1s, and the exposure is expected to expand with approvals for new indications in the pipeline, as well as a projected increase in take-up rates
It boiled down to: You need to 1) provide documentation of a positive COVID-19 test
Initial studies in rats caused concerns over GLP-1 RAs causing thyroid cancer, but human studies are less clear on whether it is a concern.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)
& Chew, E
In our study, the effect of GLP-1RA appeared greater than these underlying comorbidities, with an odds ratio of 5.4